ELUTMICRO

Elutia Inc.

HealthcareBiotechnology
$1.00
$0.00(-2.08%)
52W$0.50
$2.64
Updated May 8, 12:00 AM
RSI43
RS Rating57/99
Beta-0.11
Volatility84%
F-Score5/9
Mkt Cap$45M
CONSOLIDATING

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

CONSOLIDATING

Elutia Inc. is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is moderate (RS Rating: 57), indicating performance broadly in line with the market. Earnings growth of 7% provides fundamental context to the price action. Investors should exercise caution due to high volatility (84% annualized), which requires wider risk management.

Relative Strength
57
out of 99
Average
Trend Score
2/4
Minervini Criteria
CONSOLIDATING
Risk (Beta)
-0.11
vs S&P 500
LOW VOL
52W Position
23%
from 52W low
Lower Half
Trend & Momentum Analysis

Trend Template (Minervini)

CONSOLIDATING2/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$1.10
50 SMA > 100 SMA$0.97
100 SMA > 150 SMA$0.91
150 SMA > 200 SMA$1.12

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$1.07-7.02%BELOW
50 SMA$1.10-9.01%BELOW
100 SMA$0.97+3.15%ABOVE
150 SMA$0.91+9.37%ABOVE
200 SMA$1.12-10.84%BELOW

Price Performance

1D-2.1%
1W-2.1%
1M-13.9%
3M+5.7%
6M+11.6%
YTD+55.3%
1Y-48.0%
3Y-24.1%
52-Week Trading Range23% from low
$1.00
52W Low$0.50
52W High$2.64

Technical Indicators

RSI (14)NEUTRAL
43.3
305070
VCP ScoreCOOL
3/10
Base depth: 54.0%

Risk Profile

Beta
-0.11
52W Vol
84%
ATR
$0.06
Max DD (1Y)
-79%

Volume Analysis

Today
180.4K
50D Avg
120.7K
Vol Ratio
1.49x
Liquidity
ILLIQUID

Earnings Momentum

Q1'25+72%
$-0.21
Q2'25+77%
$-0.26
Q3'25+42%
$-0.19
Q4'25+669%
$1.48
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:
5 Years:-22.04%
3 Years:-19.82%
TTM:-49.57%

Compounded Profit Growth

10 Years:
5 Years:
3 Years:
TTM:+133.20%

Stock Price CAGR

10 Years:-23.47%
5 Years:-38.74%
3 Years:-24.05%
1 Year:-47.98%

Return on Equity

10Y Avg:-207.9%
5Y Avg:-242.3%
3Y Avg:192.9%
Last Year:192.9%

Key Metrics

Market Cap$45M
Gross Margin53.7%
Net Margin4.3%
Piotroski F-Score5/9

Frequently Asked Questions

Is ELUT in an uptrend right now?

ELUT has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.

Is ELUT overbought or oversold?

ELUT's RSI (14) is 43. The stock is in neutral territory, neither overbought nor oversold.

Is ELUT outperforming the market?

ELUT has a Relative Strength (RS) Rating of 57 out of 99. ELUT is performing about average compared to the market.

Where is ELUT in its 52-week range?

ELUT is trading at $1.00, which is 38% of its 52-week high ($2.64) and 23% above its 52-week low ($0.50).

How volatile is ELUT?

ELUT has a Beta of -0.11 and 52-week volatility of 84%. It's less volatile than the S&P 500 - generally more stable.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.